AzTrials
AzTrials

Ureteropelvic Junction ObstructionUPJO-SWENCT07624019

Renal SWE as a Predictor After Pediatric Pyeloplasty for UPJO

An observational study of Ureteropelvic Junction Obstruction and Renal Functional Recovery, run by Beni-Suef University at 1 site in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Ureteropelvic junction obstruction is an important cause of hydronephrosis and potentially reversible renal functional impairment in children. Although open pyeloplasty is an effective standard treatment, the degree of postoperative renal functional recovery varies between patients. Read more about this study

Who is it for?
Ages 6 months to 18 years
How many people
84 participants
Where
1 siteEgypt
Study dates
6 May 2026to May 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 months to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: Children aged 6 months to 18 years with unilateral primary ureteropelvic junction obstruction who are scheduled for open dismembered pyeloplasty at the Department of Urology, Faculty of Medicine, Beni-Suef University.

Who may be able to join

  • Children aged 6 months to 18 years.
  • Diagnosis of unilateral primary ureteropelvic junction obstruction.
  • Planned for open dismembered pyeloplasty.
  • Availability of preoperative renal ultrasonography, renal cortical shear wave elastography, and diuretic renography.
  • Written informed consent obtained from parent or legal guardian.

Who cannot join

  • Bilateral ureteropelvic junction obstruction.
  • Secondary ureteropelvic junction obstruction.
  • Previous ipsilateral upper urinary tract surgery.
  • Associated major urinary tract anomalies likely to independently affect renal function, including vesicoureteral reflux, megaureter, duplex system, posterior urethral valves, or ectopic kidney.
  • Active urinary tract infection at the time of assessment.
  • Known intrinsic renal parenchymal disease unrelated to obstruction.
  • Inability to obtain reliable shear wave elastography measurements.
  • Incomplete planned follow-up.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Hany F Badawy, MD contact

+201149525028

HANYFATHY86@GMAIL.COM

Ghada S Etman, MD contact

+201211874080

Drhanyfathy86@GMAIL.COM

Egypt1 site, 1 recruiting
  • Department of Urology- Beni-Suef University Hospitals

    Banī Suwayf, Beni Suweif Governorate

    Hany F Badawy, MD, +201149525028, HANYFATHY86@GMAIL.COM

    Recruiting

Other trials in Egypt

About this study

Official title: Renal Cortical Shear Wave Elastography as a Predictor of Functional Recovery After Open Pyeloplasty for Unilateral Pediatric Ureteropelvic Junction Obstruction: A Prospective Cohort Study

Ureteropelvic junction obstruction is an important cause of hydronephrosis and potentially reversible renal functional impairment in children. Although open pyeloplasty is an effective standard treatment, the degree of postoperative renal functional recovery varies between patients.

This prospective observational cohort study will evaluate whether renal cortical shear wave elastography can predict renal functional recovery after open pyeloplasty in children with unilateral primary ureteropelvic junction obstruction. Renal cortical shear wave elastography will be assessed before surgery and during follow-up, and the change in elastography values will be compared with renal isotope findings after surgery.

The primary objective is to evaluate the predictive value of the change in renal cortical shear wave elastography from baseline to 3 months after surgery for isotope-defined renal functional recovery at 6 months after open pyeloplasty.

Read the detailed description

This is a prospective longitudinal observational cohort study conducted at the Department of Urology, Faculty of Medicine, Beni-Suef University.

The study will include children aged 6 months to 18 years with unilateral primary ureteropelvic junction obstruction who are scheduled for open dismembered pyeloplasty. Eligible children will undergo standard preoperative clinical assessment, laboratory investigations, renal ultrasonography, renal cortical shear wave elastography, and renal isotope assessment.

Preoperative imaging will include renal ultrasonography to assess hydronephrosis, anteroposterior pelvic diameter, and renal cortical thickness. Renal cortical shear wave elastography will be performed to measure cortical stiffness in the affected kidney. Renal isotope assessment will include diuretic renography for differential renal function and drainage assessment, with renal cortical scintigraphy when clinically indicated according to the approved protocol.

All included patients will undergo open dismembered pyeloplasty according to standard surgical principles. Postoperative follow-up will include clinical assessment, renal ultrasonography, and renal cortical shear wave elastography at 3 and 6 months. A repeat renal isotope study will be performed at 6 months after surgery to reassess differential renal function and drainage.

The primary outcome is the predictive performance of the change in renal cortical shear wave elastography from baseline to 3 months postoperatively for 6-month isotope-defined renal functional recovery after pyeloplasty. Secondary outcomes include the association between 3-month postoperative shear wave elastography and functional recovery, longitudinal changes in shear wave elastography, postoperative changes in differential renal function and drainage parameters, and improvement in ultrasonographic parameters after pyeloplasty.

Keywords
Pediatric UPJO, Open pyeloplasty, Shear wave elastography, Renal cortical stiffness, Ureteropelvic junction obstruction
Medical subject headings
Multicystic renal dysplasia, bilateral

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07624019
Study groupRoleWhat they receive
Children With Unilateral UPJO Undergoing Open PyeloplastyChildren aged 6 months to 18 years with unilateral primary ureteropelvic junction obstruction scheduled for open dismembered pyeloplasty. Participants will undergo preoperative renal ultrasonography, renal cortical shear wave elastography, and renal isotope assessment, followed by postoperative clinical, ultrasound, shear wave elastography, and isotope follow-up according to the study protocol.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Predictive Accuracy of 3-Month Change in Renal Cortical SWE for 6-Month Functional Recovery

    The change in renal cortical shear wave elastography from baseline to 3 months after open pyeloplasty will be evaluated for its ability to predict renal functional recovery at 6 months.

    Measured: Baseline to 6 months after open pyeloplasty

Secondary outcomes (3)
  1. Association Between 3-Month Renal Cortical SWE and 6-Month Functional Recovery

    The association between the renal cortical shear wave elastography value measured at 3 months after open pyeloplasty and renal functional recovery at 6 months will be assessed.

    Measured: 3 months to 6 months after open pyeloplasty

  2. Association Between 6-Month Change in Renal Cortical SWE and 6-Month Isotope Findings

    The change in renal cortical shear wave elastography from baseline to 6 months after open pyeloplasty will be assessed in relation to 6-month renal isotope findings.

    Measured: Baseline to 6 months after open pyeloplasty

  3. Longitudinal Change in Renal Cortical SWE After Pyeloplasty

    Renal cortical shear wave elastography values will be compared over time at baseline, 3 months, and 6 months after open pyeloplasty to assess postoperative changes in renal

    Measured: Baseline, 3 months, and 6 months after open pyeloplasty.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jun 2026
  2. Study start6 May 2026
  3. Primary completionApr 2027 (estimated)
  4. Study completionMay 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
84 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07624019
Sponsor's protocol ID
FMBSUREC05052026BadawySWE
Other IDs
FMBSUREC/05052026/Badawy
Acronym
UPJO-SWE
Status last verified
May 2026
First submitted
28 May 2026
Last updated
3 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared. Only aggregated, de-identified study results will be reported. Individual-level pediatric clinical and imaging data will remain confidential and will be accessible only to the study investigators and authorized regulatory or ethics committee representatives if required.

Questions about this trial

What is this clinical trial studying?

An observational study of Ureteropelvic Junction Obstruction and Renal Functional Recovery, run by Beni-Suef University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 3 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Hany F Badawy, MD (+201149525028, HANYFATHY86@GMAIL.COM), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Predictive Accuracy of 3-Month Change in Renal Cortical SWE for 6-Month Functional Recovery (time frame: Baseline to 6 months after open pyeloplasty). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in